Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 164

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Shared inflammatory pathways of rheumatoid arthritis and atherosclerotic cardiovascular disease

Open access
Weber, Brittany N., Giles, Jon T., Liao, Katherine P. · 2023 · Nature Reviews Rheumatology

Abstract

The association between chronic inflammation and increased risk of cardiovascular disease in rheumatoid arthritis (RA) is well established. In the general population, inflammation is an established independent risk factor for cardiovascular disease, and much interest is placed on controlling inflammation to reduce cardiovascular events. As inflammation encompasses numerous pathways, the development of targeted therapies in RA provides an opportunity to understand the downstream effect of inhibiting specific pathways on cardiovascular risk. Data from these studies can inform cardiovascular risk management in patients with RA, and in the general population. This Review focuses on pro-inflammatory pathways targeted by existing therapies in RA and with mechanistic data from the general population on cardiovascular risk. Specifically, the discussions include the IL-1, IL-6 and TNF pathways, as well as the Janus kinase (JAK)–signal transducer and activator of transcription (STAT) signalling pathway, and the role of these pathways in RA pathogenesis in the joint alongside the development of atherosclerotic cardiovascular disease. Overall, some robust data support inhibition of IL-1 and IL-6 in decreasing the risk of cardiovascular disease, with growing data supporting IL-6 inhibition in both patients with RA and the general population to reduce the risk of cardiovascular disease. Rheumatoid arthritis is associated with an excess risk of atherosclerotic cardiovascular disease. This Review summarizes shared inflammatory pathways between rheumatoid arthritis and atherosclerotic cardiovascular disease that are targeted by existing therapies, and lessons learnt from clinical trials of these drugs. Rheumatoid arthritis (RA) and atherosclerotic cardiovascular disease share pro-inflammatory pathways that promote the pathogenesis of both conditions, including the IL-1 and IL-6 pathways. Inflammation encompasses numerous pathways, and data from studies of targeted therapies developed for RA can provide insight into the potential effects of these therapies on cardiovascular risk. Targeting IL-6 is considered more effective in controlling RA disease activity than targeting IL-1 and robust data also suggest that this therapy can reduce atherosclerotic cardiovascular disease risk in the general population. Targeting some pro-inflammatory pathway(s), such as the TNF pathway, might be more beneficial than targeting others, such as JAK–STAT signalling, in reducing cardiovascular risk. Rheumatoid arthritis (RA) and atherosclerotic cardiovascular disease share pro-inflammatory pathways that promote the pathogenesis of both conditions, including the IL-1 and IL-6 pathways. Inflammation encompasses numerous pathways, and data from studies of targeted therapies developed for RA can provide insight into the potential effects of these therapies on cardiovascular risk. Targeting IL-6 is considered more effective in controlling RA disease activity than targeting IL-1 and robust data also suggest that this therapy can reduce atherosclerotic cardiovascular disease risk in the general population. Targeting some pro-inflammatory pathway(s), such as the TNF pathway, might be more beneficial than targeting others, such as JAK–STAT signalling, in reducing cardiovascular risk.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41584-023-00969-7

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 164

Metadata

Authors
Weber, B. N., Giles, J. T., & Liao, K. P.
Venue
Nature Reviews Rheumatology
Published
2023-05-25
Volume
19
Issue
7
Pages
417-428
ISSN
  • 1759-4790 (ISSN-L)
  • 1759-4804
OpenAlex
W4378212336
Cited by
164
References
22
FWCI
11.41
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Shared inflammatory pathways of rheumatoid arthritis and atherosclerotic cardiovascular disease. https://app.cochat.ai/papers/10.1038/s41584-023-00969-7
The paper
Weber, B. N., Giles, J. T., & Liao, K. P. (2023). Shared inflammatory pathways of rheumatoid arthritis and atherosclerotic cardiovascular disease. Nature Reviews Rheumatology. https://doi.org/10.1038/s41584-023-00969-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.